Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 377

1.

Clinical study of 19 patients with SCN8A-related epilepsy: Two modes of onset regarding EEG and seizures.

Denis J, Villeneuve N, Cacciagli P, Mignon-Ravix C, Lacoste C, Lefranc J, Napuri S, Damaj L, Villega F, Pedespan JM, Moutton S, Mignot C, Doummar D, Lion-François L, Gataullina S, Dulac O, Martin M, Gueden S, Lesca G, Julia S, Cances C, Journel H, Altuzarra C, Ben Zeev B, Afenjar A, Barth M, Villard L, Milh M.

Epilepsia. 2019 May;60(5):845-856. doi: 10.1111/epi.14727. Epub 2019 Apr 26.

PMID:
31026061
2.

New insights in phenomenology and treatment of epilepsy in CDKL5 encephalopathy.

Melikishvili G, Epitashvili N, Tabatadze N, Chikvinidze G, Dulac O, Bienvenu T, Gataullina S.

Epilepsy Behav. 2019 May;94:308-311. doi: 10.1016/j.yebeh.2019.02.013. Epub 2019 Mar 18.

PMID:
30898514
3.

Gene mutations in paediatric epilepsies cause NMDA-pathy, and phasic and tonic GABA-pathy.

Gataullina S, Bienvenu T, Nabbout R, Huberfeld G, Dulac O.

Dev Med Child Neurol. 2019 Jan 25. doi: 10.1111/dmcn.14152. [Epub ahead of print] Review.

PMID:
30680721
4.

Pharmacokinetic evaluation of vigabatrin dose for the treatment of refractory focal seizures in children using adult and pediatric data.

Rodrigues C, Chiron C, Ounissi M, Dulac O, Gaillard S, Nabbout R, Jullien V.

Epilepsy Res. 2019 Feb;150:38-45. doi: 10.1016/j.eplepsyres.2019.01.002. Epub 2019 Jan 7.

PMID:
30639958
5.

Early and long-term electroclinical features of patients with epilepsy and PCDH19 mutation.

Chemaly N, Losito E, Pinard JM, Gautier A, Villeneuve N, Arbues AS, An I, Desguerre I, Dulac O, Chiron C, Kaminska A, Nabbout R.

Epileptic Disord. 2018 Dec 1;20(6):457-467. doi: 10.1684/epd.2018.1009.

PMID:
30530412
6.

Proposition of a Minimal Effective Dose of Vigabatrin for the Treatment of Infantile Spasms Using Pediatric and Adult Pharmacokinetic Data.

Ounissi M, Rodrigues C, Bienayme H, Duhamel P, Pons G, Dulac O, Nabbout R, Chiron C, Jullien V.

J Clin Pharmacol. 2019 Feb;59(2):177-188. doi: 10.1002/jcph.1309. Epub 2018 Sep 7.

PMID:
30192381
7.

Do children with Dravet syndrome continue to benefit from stiripentol for long through adulthood?

Chiron C, Helias M, Kaminska A, Laroche C, de Toffol B, Dulac O, Nabbout R, An I.

Epilepsia. 2018 Sep;59(9):1705-1717. doi: 10.1111/epi.14536. Epub 2018 Aug 22.

PMID:
30132836
8.

Epilepsy in Biotinidase Deficiency Is Distinct from Early Myoclonic Encephalopathy.

Guliyeva U, Okur I, Dulac O, Khalilov O, Guliyeva S.

Neuropediatrics. 2018 Dec;49(6):417-418. doi: 10.1055/s-0038-1666845. Epub 2018 Jul 12.

PMID:
30001564
9.

A population pharmacokinetic model taking into account protein binding for the sustained-release granule formulation of valproic acid in children with epilepsy.

Rodrigues C, Chhun S, Chiron C, Dulac O, Rey E, Pons G, Jullien V.

Eur J Clin Pharmacol. 2018 Jun;74(6):793-803. doi: 10.1007/s00228-018-2444-2. Epub 2018 Mar 21.

PMID:
29564480
10.

Is epilepsy the cause of comorbidities in Dravet syndrome?

Gataullina S, Dulac O.

Dev Med Child Neurol. 2018 Jan;60(1):8. doi: 10.1111/dmcn.13613. Epub 2017 Nov 10. No abstract available.

11.

Population pharmacokinetics of oxcarbazepine and its monohydroxy derivative in epileptic children.

Rodrigues C, Chiron C, Rey E, Dulac O, Comets E, Pons G, Jullien V.

Br J Clin Pharmacol. 2017 Dec;83(12):2695-2708. doi: 10.1111/bcp.13392. Epub 2017 Sep 20.

12.

Outcome of childhood-onset epilepsy from adolescence to adulthood: Transition issues.

Nabbout R, Andrade DM, Bahi-Buisson N, Cross H, Desquerre I, Dulac O, Granata T, Hirsch E, Navarro V, Ouss L, Pearl PL, Schmidt D, Thiele E, Camfield PR, Camfield CS.

Epilepsy Behav. 2017 Apr;69:161-169. doi: 10.1016/j.yebeh.2016.11.010. Epub 2017 Feb 28. Review.

PMID:
28256379
13.

Language plasticity after hemispherotomy of the dominant hemisphere in 3 patients: Implication of non-linguistic networks.

Bulteau C, Jambaqué I, Chiron C, Rodrigo S, Dorfmüller G, Dulac O, Hertz-Pannier L, Noulhiane M.

Epilepsy Behav. 2017 Apr;69:86-94. doi: 10.1016/j.yebeh.2017.01.004. Epub 2017 Feb 23.

PMID:
28236728
14.

From genotype to phenotype in Dravet disease.

Gataullina S, Dulac O.

Seizure. 2017 Jan;44:58-64. doi: 10.1016/j.seizure.2016.10.014. Epub 2016 Oct 21. Review.

15.

Epileptic Phenotype of Two Siblings with Asparagine Synthesis Deficiency Mimics Neonatal Pyridoxine-Dependent Epilepsy.

Gataullina S, Lauer-Zillhardt J, Kaminska A, Galmiche-Rolland L, Bahi-Buisson N, Pontoizeau C, Ottolenghi C, Dulac O, Fallet-Bianco C.

Neuropediatrics. 2016 Dec;47(6):399-403. Epub 2016 Aug 14.

PMID:
27522229
16.

Patients with dravet syndrome in the era of stiripentol: A French cohort cross-sectional study.

De Liso P, Chemaly N, Laschet J, Barnerias C, Hully M, Leunen D, Desguerre I, Chiron C, Dulac O, Nabbout R.

Epilepsy Res. 2016 Sep;125:42-6. doi: 10.1016/j.eplepsyres.2016.05.012. Epub 2016 May 28.

PMID:
27389706
17.

Motor neuropathy contributes to crouching in patients with Dravet syndrome.

Gitiaux C, Chemaly N, Quijano-Roy S, Barnerias C, Desguerre I, Hully M, Chiron C, Dulac O, Nabbout R.

Neurology. 2016 Jul 19;87(3):277-81. doi: 10.1212/WNL.0000000000002859. Epub 2016 Jun 17.

PMID:
27316242
18.

Dynamic changes of depolarizing GABA in a computational model of epileptogenic brain: Insight for Dravet syndrome.

Kurbatova P, Wendling F, Kaminska A, Rosati A, Nabbout R, Guerrini R, Dulac O, Pons G, Cornu C, Nony P; CRESIM/EpiCRESIM Study Group, Chiron C, Benquet P.

Exp Neurol. 2016 Sep;283(Pt A):57-72. doi: 10.1016/j.expneurol.2016.05.037. Epub 2016 May 28.

19.

Novel GABRG2 mutations cause familial febrile seizures.

Boillot M, Morin-Brureau M, Picard F, Weckhuysen S, Lambrecq V, Minetti C, Striano P, Zara F, Iacomino M, Ishida S, An-Gourfinkel I, Daniau M, Hardies K, Baulac M, Dulac O, Leguern E, Nabbout R, Baulac S.

Neurol Genet. 2015 Nov 4;1(4):e35. doi: 10.1212/NXG.0000000000000035. eCollection 2015 Dec.

20.

Epilepsy in young Tsc1(+/-) mice exhibits age-dependent expression that mimics that of human tuberous sclerosis complex.

Gataullina S, Lemaire E, Wendling F, Kaminska A, Watrin F, Riquet A, Ville D, Moutard ML, de Saint Martin A, Napuri S, Pedespan JM, Eisermann M, Bahi-Buisson N, Nabbout R, Chiron C, Dulac O, Huberfeld G.

Epilepsia. 2016 Apr;57(4):648-59. doi: 10.1111/epi.13325. Epub 2016 Feb 13.

21.

Mutations in RIT1 cause Noonan syndrome with possible juvenile myelomonocytic leukemia but are not involved in acute lymphoblastic leukemia.

Cavé H, Caye A, Ghedira N, Capri Y, Pouvreau N, Fillot N, Trimouille A, Vignal C, Fenneteau O, Alembik Y, Alessandri JL, Blanchet P, Boute O, Bouvagnet P, David A, Dieux Coeslier A, Doray B, Dulac O, Drouin-Garraud V, Gérard M, Héron D, Isidor B, Lacombe D, Lyonnet S, Perrin L, Rio M, Roume J, Sauvion S, Toutain A, Vincent-Delorme C, Willems M, Baumann C, Verloes A.

Eur J Hum Genet. 2016 Aug;24(8):1124-31. doi: 10.1038/ejhg.2015.273. Epub 2016 Jan 13.

22.

Language recovery after left hemispherotomy for Rasmussen encephalitis.

Bulteau C, Grosmaitre C, Save-Pédebos J, Leunen D, Delalande O, Dorfmüller G, Dulac O, Jambaqué I.

Epilepsy Behav. 2015 Dec;53:51-7. doi: 10.1016/j.yebeh.2015.07.044. Epub 2015 Oct 28.

PMID:
26519666
23.

Mosaic parental germline mutations causing recurrent forms of malformations of cortical development.

Zillhardt JL, Poirier K, Broix L, Lebrun N, Elmorjani A, Martinovic J, Saillour Y, Muraca G, Nectoux J, Bessieres B, Fallet-Bianco C, Lyonnet S, Dulac O, Odent S, Rejeb I, Ben Jemaa L, Rivier F, Pinson L, Geneviève D, Musizzano Y, Bigi N, Leboucq N, Giuliano F, Philip N, Vilain C, Van Bogaert P, Maurey H, Beldjord C, Artiguenave F, Boland A, Olaso R, Masson C, Nitschké P, Deleuze JF, Bahi-Buisson N, Chelly J.

Eur J Hum Genet. 2016 Apr;24(4):611-4. doi: 10.1038/ejhg.2015.192. Epub 2015 Sep 23.

24.

The ketogenic diet can be used successfully in combination with corticosteroids for epileptic encephalopathies.

Ville D, Chiron C, Laschet J, Dulac O.

Epilepsy Behav. 2015 Jul;48:61-5. doi: 10.1016/j.yebeh.2015.03.003. Epub 2015 Jun 8.

PMID:
26057351
25.

Temporal lobe epilepsy in infants and children.

Gataullina S, Dulac O, Bulteau C.

Rev Neurol (Paris). 2015 Mar;171(3):252-8. doi: 10.1016/j.neurol.2015.01.559. Epub 2015 Mar 2. Review.

PMID:
25744768
26.

Pharmacokinetics of clobazam and N-desmethylclobazam in children with dravet syndrome receiving concomitant stiripentol and valproic Acid.

Jullien V, Chhun S, Rey E, Dulac O, Tod M, Chiron C, Pons G.

Clin Pharmacokinet. 2015 May;54(5):527-36. doi: 10.1007/s40262-014-0223-5.

PMID:
25503589
27.

Human slack potassium channel mutations increase positive cooperativity between individual channels.

Kim GE, Kronengold J, Barcia G, Quraishi IH, Martin HC, Blair E, Taylor JC, Dulac O, Colleaux L, Nabbout R, Kaczmarek LK.

Cell Rep. 2014 Dec 11;9(5):1661-1672. doi: 10.1016/j.celrep.2014.11.015. Epub 2014 Dec 4.

28.

Seizures and epilepsy in hypoglycaemia caused by inborn errors of metabolism.

Gataullina S, Delonlay P, Lemaire E, Boddaert N, Bulteau C, Soufflet C, Laín GA, Nabbout R, Chiron C, Dulac O.

Dev Med Child Neurol. 2015 Feb;57(2):194-9. doi: 10.1111/dmcn.12574. Epub 2014 Aug 22.

29.

Analysis of vigabatrin treatment causing visual field defects in infantile spasms.

Chiron C, Dulac O.

Dev Med Child Neurol. 2015 Jan;57(1):9-10. doi: 10.1111/dmcn.12558. Epub 2014 Aug 11. No abstract available.

30.

Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model.

Lozovaya N, Gataullina S, Tsintsadze T, Tsintsadze V, Pallesi-Pocachard E, Minlebaev M, Goriounova NA, Buhler E, Watrin F, Shityakov S, Becker AJ, Bordey A, Milh M, Scavarda D, Bulteau C, Dorfmuller G, Delalande O, Represa A, Cardoso C, Dulac O, Ben-Ari Y, Burnashev N.

Nat Commun. 2014 Aug 1;5:4563. doi: 10.1038/ncomms5563.

31.

Occasional seizures, epilepsy, and inborn errors of metabolism.

Dulac O, Plecko B, Gataullina S, Wolf NI.

Lancet Neurol. 2014 Jul;13(7):727-39. doi: 10.1016/S1474-4422(14)70110-3. Review.

PMID:
24943345
32.

Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines.

Coppola G, Besag F, Cusmai R, Dulac O, Kluger G, Moavero R, Nabbout R, Nikanorova M, Pisani F, Verrotti A, von Stülpnagel C, Curatolo P.

Eur J Paediatr Neurol. 2014 Nov;18(6):685-90. doi: 10.1016/j.ejpn.2014.05.008. Epub 2014 May 28. Review.

PMID:
24929673
33.

Reassessment of stiripentol pharmacokinetics in healthy adult volunteers.

Peigné S, Rey E, Le Guern ME, Dulac O, Chiron C, Pons G, Jullien V.

Epilepsy Res. 2014 Jul;108(5):909-16. doi: 10.1016/j.eplepsyres.2014.03.009. Epub 2014 Mar 26.

PMID:
24725808
34.

Mutations in QARS, encoding glutaminyl-tRNA synthetase, cause progressive microcephaly, cerebral-cerebellar atrophy, and intractable seizures.

Zhang X, Ling J, Barcia G, Jing L, Wu J, Barry BJ, Mochida GH, Hill RS, Weimer JM, Stein Q, Poduri A, Partlow JN, Ville D, Dulac O, Yu TW, Lam AT, Servattalab S, Rodriguez J, Boddaert N, Munnich A, Colleaux L, Zon LI, Söll D, Walsh CA, Nabbout R.

Am J Hum Genet. 2014 Apr 3;94(4):547-58. doi: 10.1016/j.ajhg.2014.03.003. Epub 2014 Mar 20.

35.

Auditory stimuli mimicking ambient sounds drive temporal "delta-brushes" in premature infants.

Chipaux M, Colonnese MT, Mauguen A, Fellous L, Mokhtari M, Lezcano O, Milh M, Dulac O, Chiron C, Khazipov R, Kaminska A.

PLoS One. 2013 Nov 11;8(11):e79028. doi: 10.1371/journal.pone.0079028. eCollection 2013.

36.

Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy.

Nabbout R, Chemaly N, Chipaux M, Barcia G, Bouis C, Dubouch C, Leunen D, Jambaqué I, Dulac O, Dellatolas G, Chiron C.

Orphanet J Rare Dis. 2013 Nov 13;8:176. doi: 10.1186/1750-1172-8-176.

37.

Early epileptic encephalopathies associated with STXBP1 mutations: Could we better delineate the phenotype?

Barcia G, Chemaly N, Gobin S, Milh M, Van Bogaert P, Barnerias C, Kaminska A, Dulac O, Desguerre I, Cormier V, Boddaert N, Nabbout R.

Eur J Med Genet. 2014 Jan;57(1):15-20. doi: 10.1016/j.ejmg.2013.10.006. Epub 2013 Nov 1.

PMID:
24189369
38.

Transition and transfer from pediatric to adult health care in epilepsy: a families' survey on Dravet syndrome.

Kuchenbuch M, Chemaly N, Chiron C, Dulac O, Nabbout R.

Epilepsy Behav. 2013 Oct;29(1):161-5. doi: 10.1016/j.yebeh.2013.07.015. Epub 2013 Aug 22.

PMID:
23973640
39.

Hemiconvulsion-hemiplegia syndrome revisited: longitudinal MRI findings in 10 children.

Barcia G, Desguerre I, Carmona O, Barnerias C, Chemaly N, Gitiaux C, Brunelle F, Dulac O, Boddaert N, Nabbout R.

Dev Med Child Neurol. 2013 Dec;55(12):1150-8. doi: 10.1111/dmcn.12233. Epub 2013 Aug 8.

40.

Early electro-clinical features may contribute to diagnosis of the anti-NMDA receptor encephalitis in children.

Gitiaux C, Simonnet H, Eisermann M, Leunen D, Dulac O, Nabbout R, Chevignard M, Honnorat J, Gataullina S, Musset L, Scalais E, Gauthier A, Hully M, Boddaert N, Kuchenbuch M, Desguerre I, Kaminska A.

Clin Neurophysiol. 2013 Dec;124(12):2354-61. doi: 10.1016/j.clinph.2013.05.023. Epub 2013 Jul 2. Erratum in: Clin Neurophysiol. 2014 Jun;125(6):1288.

PMID:
23830005
41.

Children often present with infantile spasms after herpetic encephalitis.

Aznar Laín G, Dellatolas G, Eisermann M, Boddaert N, Chiron C, Bulteau C, Monteiro JP, An I, Pédespan JM, Cancès C, Peudenier S, Barthez MA, Milh M, Dorfmuller G, Héron B, Nabbout R, Grevent D, Dulac O.

Epilepsia. 2013 Sep;54(9):1571-6. doi: 10.1111/epi.12258. Epub 2013 Jul 1.

42.

Postnatal toxic and acquired disorders.

Saint-Amour D, Dallaire R, Dulac O.

Handb Clin Neurol. 2013;113:1927-35. doi: 10.1016/B978-0-444-59565-2.00063-0. Review.

PMID:
23622416
43.

Epileptic encephalopathy with suppression-bursts and nonketotic hyperglycinemia.

Dulac O.

Handb Clin Neurol. 2013;113:1785-97. doi: 10.1016/B978-0-444-59565-2.00048-4. Review.

PMID:
23622401
44.

Pediatric neurology.

Dulac O, Lassonde M, Sarnat HB.

Handb Clin Neurol. 2013;111:ix. doi: 10.1016/B978-0-444-52891-9.09995-4. No abstract available.

PMID:
23622230
45.

Status epilepticus.

Dulac O, Takahashi T.

Handb Clin Neurol. 2013;111:681-9. doi: 10.1016/B978-0-444-52891-9.00070-1. Review.

PMID:
23622215
46.

Epilepsy in inborn errors of metabolism.

Bahi-Buisson N, Dulac O.

Handb Clin Neurol. 2013;111:533-41. doi: 10.1016/B978-0-444-52891-9.00056-7. Review.

PMID:
23622201
47.

Brain maturation and epilepsy.

Dulac O, Milh M, Holmes GL.

Handb Clin Neurol. 2013;111:441-6. doi: 10.1016/B978-0-444-52891-9.00047-6. Review.

PMID:
23622192
48.

[Brain maturation and epilepsy].

Dulac O, Milh M.

Rev Prat. 2012 Dec;62(10):1371-7. Review. French.

PMID:
23424914
49.

A revisited strategy for antiepileptic drug development in children: designing an initial exploratory step.

Chiron C, Kassai B, Dulac O, Pons G, Nabbout R.

CNS Drugs. 2013 Mar;27(3):185-95. doi: 10.1007/s40263-012-0035-9. Review.

PMID:
23345029
50.

Optimizing statistical parametric mapping analysis of 18F-FDG PET in children.

Archambaud F, Bouilleret V, Hertz-Pannier L, Chaumet-Riffaud P, Rodrigo S, Dulac O, Chassoux F, Chiron C.

EJNMMI Res. 2013 Jan 4;3(1):2. doi: 10.1186/2191-219X-3-2.

Supplemental Content

Support Center